One in three Canadians are currently living with obesity, and in 10 years, that number is going to change to about 50 per cent, so this is really an opportunity for policymakers to take action. LISTEN | WHO conditionally recommends GLP-1 drugs for obesity: The WHOs first conditional recommendation advises the use of GLP-1 drugs by adults, except pregnant women, for long-term obesity treatment, while the second suggests interventions like a healthy diet and physical activity to be offered alongside the medicines
Cardiovascular adaptation represents another consideration for extended use
| TSH monitoring on Wegovy | Weight loss and your levothyroxine dose | Eating well on both medications | Staying active | Wegovy versus other weight-loss medications | Frequently asked questions | Take home message You can take Wegovy (semaglutide) with levothyroxine
Raniga, K
Social media discussions often focus on dramatic outcomes, but medical evidence looks at a fuller picture: who may benefit, what side effects occur, how durable the results are, and whether the medicine is safe in the long term